Novo Nordisk CEO Exit Signals Strategic Recalibration Amid Investor Pressure and Foundation Power Shift

Novo Nordisk’s announcement of an executive reshuffle marks more than a routine leadership transition. It signals a strat...

May 19, 2025 | Monday | Analysis
Merck CEO Belén Garijo Steers Strong Q1 as Process Solutions Powers Growth and Strategic Vision

Net sales increased organically by 2.5% to € 5.3 billion EBITDA pre up organically by 5.8% to € 1.5 billion All three b...

May 15, 2025 | Thursday | Company results
Ecolab Opens Bioprocessing Applications Lab in Eastern U.S. to Boost Biotherapeutic Purification Support

  The new facility is designed to support biopharma customers with applications and process development for the purification of biotherapeutic molecu...

May 15, 2025 | Thursday | News
Azenta’s GENEWIZ and Form Bio Partner to Accelerate AAV Gene Therapy Development with Integrated Sequencing and AI Analysis

Integrated solution aims to reduce time and cost to lead candidates, advancing safer and more effective gene therapies to patients faster. Azenta, Inc.a...

May 14, 2025 | Wednesday | News
Biocom California and KoreaBIO Sign MOU to Strengthen US-Korea Life Science Collaboration

Biocom California, the association representing the California life science industry, and KoreaBIO, a life science trade association which seeks to solid...

May 13, 2025 | Tuesday | News
Conduit Pharmaceuticals Secures Korean Patent for AZD1656, Strengthening Global IP Portfolio for Autoimmune Drug

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals", "Conduit" or the “Company”) today announces that the Korean Intellectu...

May 12, 2025 | Monday | News
LENZ Therapeutics and Lotus Pharmaceutical Ink $125M Licensing Deal to Commercialize LNZ100 for Presbyopia in Asia

LENZ Therapeutics, Inc.  and Lotus Pharmaceutical Co., Ltd. y announced an exclusive license and commercialization agreement for Lotus to commercial...

May 12, 2025 | Monday | News
PL BioScience and DewCell Introduce First Artificial Human Platelet Lysate Enabling Scalable Xeno-Free Cell Therapy Manufacturing

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research & production of cell-based pharmaceutical...

May 09, 2025 | Friday | News
Qosina Partners with Sealed Air to Expand Bioprocessing Portfolio with NEXCEL® BIO1250 High-Performance Bag Film

Qosina, a global leader in the distribution of single-use medical and biopharmaceutical components, is proud to announce a new strategic partnership with...

May 09, 2025 | Friday | News
GeneFab and RegCell Unite to Accelerate U.S. Clinical Manufacturing of Next-Gen Treg Therapies

GeneFab, a next-generation cell and gene therapy-focused contract research, development, and manufacturing organization (CRDMO), has partnered with RegCe...

May 08, 2025 | Thursday | News
Moleculin Secures Two New U.S. Patents for Annamycin, Expanding IP Protection Through 2040

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfoli...

May 06, 2025 | Tuesday | News
Roquette Announces New Organizational Structure Following IFF Pharma Solutions Acquisition

Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces today a new organizati...

May 05, 2025 | Monday | News
Inventiva CEO Frederic Cren Confirms Completion of NATiV3 Enrollment, Eyes Approval Path for Lanifibranor in MASH

Inventiva , a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic...

May 05, 2025 | Monday | Company results
CEO Chris Cargill Marks One-Year Transformation Milestone as Nxera Pharma Reports Strong Q1 2025 Progress

Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated resu...

May 05, 2025 | Monday | Company results

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close